16-56892916-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001126108.2(SLC12A3):​c.2420-37T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.543 in 1,568,198 control chromosomes in the GnomAD database, including 233,177 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 26753 hom., cov: 35)
Exomes 𝑓: 0.54 ( 206424 hom. )

Consequence

SLC12A3
NM_001126108.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.987

Publications

10 publications found
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SLC12A3 Gene-Disease associations (from GenCC):
  • Gitelman syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 16-56892916-T-C is Benign according to our data. Variant chr16-56892916-T-C is described in ClinVar as Benign. ClinVar VariationId is 1184683.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.673 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A3NM_001126108.2 linkc.2420-37T>C intron_variant Intron 20 of 25 ENST00000563236.6 NP_001119580.2
SLC12A3NM_000339.3 linkc.2447-37T>C intron_variant Intron 20 of 25 NP_000330.3
SLC12A3NM_001126107.2 linkc.2444-37T>C intron_variant Intron 20 of 25 NP_001119579.2
SLC12A3NM_001410896.1 linkc.2417-37T>C intron_variant Intron 20 of 25 NP_001397825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A3ENST00000563236.6 linkc.2420-37T>C intron_variant Intron 20 of 25 1 NM_001126108.2 ENSP00000456149.2
SLC12A3ENST00000438926.6 linkc.2447-37T>C intron_variant Intron 20 of 25 1 ENSP00000402152.2
SLC12A3ENST00000566786.5 linkc.2444-37T>C intron_variant Intron 20 of 25 1 ENSP00000457552.1
SLC12A3ENST00000262502.5 linkc.2417-37T>C intron_variant Intron 20 of 25 5 ENSP00000262502.5

Frequencies

GnomAD3 genomes
AF:
0.588
AC:
89529
AN:
152170
Hom.:
26721
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.679
Gnomad AMI
AF:
0.681
Gnomad AMR
AF:
0.595
Gnomad ASJ
AF:
0.639
Gnomad EAS
AF:
0.631
Gnomad SAS
AF:
0.501
Gnomad FIN
AF:
0.591
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.530
Gnomad OTH
AF:
0.601
GnomAD2 exomes
AF:
0.567
AC:
136085
AN:
240136
AF XY:
0.558
show subpopulations
Gnomad AFR exome
AF:
0.687
Gnomad AMR exome
AF:
0.612
Gnomad ASJ exome
AF:
0.633
Gnomad EAS exome
AF:
0.621
Gnomad FIN exome
AF:
0.586
Gnomad NFE exome
AF:
0.532
Gnomad OTH exome
AF:
0.573
GnomAD4 exome
AF:
0.538
AC:
761601
AN:
1415910
Hom.:
206424
Cov.:
23
AF XY:
0.537
AC XY:
379232
AN XY:
706660
show subpopulations
African (AFR)
AF:
0.695
AC:
22622
AN:
32536
American (AMR)
AF:
0.610
AC:
26873
AN:
44064
Ashkenazi Jewish (ASJ)
AF:
0.634
AC:
16326
AN:
25764
East Asian (EAS)
AF:
0.630
AC:
24769
AN:
39324
South Asian (SAS)
AF:
0.504
AC:
42815
AN:
84888
European-Finnish (FIN)
AF:
0.580
AC:
30725
AN:
52972
Middle Eastern (MID)
AF:
0.590
AC:
3312
AN:
5612
European-Non Finnish (NFE)
AF:
0.524
AC:
561488
AN:
1071998
Other (OTH)
AF:
0.556
AC:
32671
AN:
58752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
17328
34656
51985
69313
86641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16030
32060
48090
64120
80150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.588
AC:
89615
AN:
152288
Hom.:
26753
Cov.:
35
AF XY:
0.591
AC XY:
44015
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.679
AC:
28244
AN:
41576
American (AMR)
AF:
0.596
AC:
9116
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.639
AC:
2218
AN:
3472
East Asian (EAS)
AF:
0.632
AC:
3267
AN:
5172
South Asian (SAS)
AF:
0.498
AC:
2403
AN:
4822
European-Finnish (FIN)
AF:
0.591
AC:
6268
AN:
10612
Middle Eastern (MID)
AF:
0.646
AC:
190
AN:
294
European-Non Finnish (NFE)
AF:
0.530
AC:
36020
AN:
68012
Other (OTH)
AF:
0.601
AC:
1268
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
2002
4005
6007
8010
10012
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.529
Hom.:
2226

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hypokalemia-hypomagnesemia Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.38
DANN
Benign
0.73
PhyloP100
-0.99
Mutation Taster
=7/93
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2278489; hg19: chr16-56926828; COSMIC: COSV52636947; API